ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2562

Human Seroreactivity to Gut Microbiota Antigens in Rheumatoid Arthritis and Controls-Lack of Association with Rheumatoid Arthritis Autoantibodies

Carol Hitchon1, Charles O. Elson2, David Robinson3, Irene Smolik3 and Hani S. El-Gabalawy1, 1University of Manitoba, Winnipeg, MB, Canada, 2Dept of Medicine, University of Alabama at Birmingham, Birmingham, AL, 3Arthritis Center, University of Manitoba, Winnipeg, MB, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Microbiome and rheumatoid arthritis, pathogenesis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Rheumatoid Arthritis – Human Etiology and Pathogenesis - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The human gut microbiome maintains normal immune homeostasis. Changes to the microbiota evolve with aging and have been implicated in the development of autoimmune disorders like rheumatoid arthritis (RA). Given the observed variability in microbiota composition among healthy individuals, immune responses to commensal microbiota may be more relevant to disease development. We compared adaptive immune responses to gut microbiota in RA patients and healthy controls and determined associations with RA autoantibodies.

Methods: IgG immune responses to intestinal microbiota were detected in sera of RA patients and controls using a protein microarray containing recombinant antigens cloned from murine microbiota that have been previously studied in humans (50 epitopes from >6 bacterial groups ). Each antigen was present in quadruplicate per slide. Bound human sera IgG was detected and quantitated using an Axon GenePix 4000B dual laser and its software. Levels are reported as median net fluorescent values with lower detectable cut-off being assigned 0. Anti-citrullinated peptide antibodies (ACPA) were measured by ELISA and rheumatoid factor (RF) by nephelometry. Associations of IgG microbiota responses with subject group and RA antibodies were tested by nonparametric tests. Patterns of microbiota responses were assessed using non-hierarchical clustering. Given multiple comparisons, p values<0.001 were considered significant.

Results: RA patients (n=121; 78% female, mean (SD) age 58 (14) years; 43 with symptoms less than 12 months (ERA)) were compared to healthy controls ( n=19, 63% female, mean(SD) age 39 (11)years). All anti-microbial IgG levels were detected in at least some subjects although there was individual variation in the expression patterns. No robust grouping of microbial responses was seen. Levels of 16 anti-microbial IgG titers were significantly elevated in RA compared to controls whereas levels of 2 anti-microbial IgGs titers were decreased (all p<0.001). The epitopes with the highest IgG titers in RA compared to controls were rIB2 (firmicutes/bacteroides) and Pmel. The epitopes with the most reduced IgG titers in RA compared to control were Ftsz (proteobacteria) and rib16 (firmicute). Of four known universal gut microbiotia antigens (rIB1, rIB2, rIB10 and rIB20), only anti-rIB2 IgG levels were increased in RA (p<0.001). There were no robust associations of individual IgG titers with ACPA or RF positivity. The levels of five anti-microbial antigen IgG titers (3-2, bir1, cbir15, cbir63, m18-1) were higher in RA of recent onset than long standing RA (all p<0.0001).

Conclusion: Adaptive immune responses to selective gut microbiota differ between RA and controls but do not associate with other RA autoantibodies. Although environmental influences such as diet and medication were not addressed here, these results suggest a broader immune response alteration to microbial organisms exists in persons with disease.


Disclosure: C. Hitchon, None; C. O. Elson, None; D. Robinson, None; I. Smolik, None; H. S. El-Gabalawy, CIHR, 2.

To cite this abstract in AMA style:

Hitchon C, Elson CO, Robinson D, Smolik I, El-Gabalawy HS. Human Seroreactivity to Gut Microbiota Antigens in Rheumatoid Arthritis and Controls-Lack of Association with Rheumatoid Arthritis Autoantibodies [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/human-seroreactivity-to-gut-microbiota-antigens-in-rheumatoid-arthritis-and-controls-lack-of-association-with-rheumatoid-arthritis-autoantibodies/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/human-seroreactivity-to-gut-microbiota-antigens-in-rheumatoid-arthritis-and-controls-lack-of-association-with-rheumatoid-arthritis-autoantibodies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology